Compass Pathways Plc buy BiotechBee
Start price
08.06.25
/
60%
€4.26
Target price
31.08.27
€8.00
Performance (%)
-43.66%
End price
29.06.25
€2.40
Summary
This prediction ended on 29.06.25 with a price of €2.40. The BUY prediction by BiotechBee for Compass Pathways Plc performed very badly with a performance of -43.66%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Compass Pathways Plc | - | - |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
According to BiotechBee what are the pros and cons of Compass Pathways Plc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year